News

Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the efficacy and safety of ruxolitinib (Jakafi)…
Read More...

HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19…
Read More...

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that it…
Read More...

Synthon Biopharmaceuticals B.V., a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless cancers and autoimmune…
Read More...

FORMA Therapeutics, Inc. (FORMA), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Vir Biotechnology, Inc. announced additional interim data from the ongoing Phase 2 trial in patients and results from the Phase 1 trial in healthy volunteers of VIR-2218, an…
Read More...

FUJIFILM Corporation has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral…
Read More...

TScan Therapeutics, a biopharmaceutical company focused on the development of T cell receptor (TCR) therapies which reprogram a patient’s own T cells to recognize shared cancer targets,…
Read More...

Merck, known as MSD outside the United States and Canada, announced the U.S. launch of ONTRUZANT (trastuzumab-dttb), as a biosimilar of the reference biologic medicine Herceptin.…
Read More...

Applied DNA Sciences Inc. announced that it has completed design qualification, production and shipment of five COVID-19 vaccine candidates to Italy-based Takis Biotech (“Takis”), a…
Read More...

IMMUNOPRECISE ANTIBODIES LTD. announced that it, through its subsidiary Talem Therapeutics, has entered into a research license agreement (the "Agreement") with Janssen Research &…
Read More...

Intensity Therapeutics announced it has entered into a clinical trial collaboration agreement with Bristol Myers Squibb Company. The program will evaluate the safety and efficacy of…
Read More...

Sinovac Biotech Ltd. announced that the Company has obtained approval to conduct a human clinical trial on an inactivated SARS-CoV-2 (commonly referred to as COVID-19) vaccine…
Read More...

PharmaJet, the maker of innovative, needle-free injection technology, announced that its Tropis Needle-free injection system will be used to deliver a COVID-19 vaccine being developed…
Read More...

AstraZeneca will initiate a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm)…
Read More...

Sanofi and GSK announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both…
Read More...

Immunotherapy companies led by Dr. Patrick Soon-Shiong are developing potential coronavirus therapeutics and vaccines to address the evolving stages of disease from moderate infection…
Read More...

Insilico Medicine announced that it has entered into a research collaboration with Boehringer Ingelheim to utilize Insilico's generative machine learning technology and proprietary…
Read More...

Ascletis Pharma Inc. announces that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F…
Read More...

Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available…
Read More...